MSB 3.33% $1.40 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-176

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,991 Posts.
    lightbulb Created with Sketch. 2112
    You're spot on.

    But there are some barriers to trial participation -

    - You would need to be in the right hospital
    - You would need to meet all of the inclusion criteria and none of the exclusion criteria
    - You would need to be approached by the right people to discuss potential trial participation (hopefully you're lucid enough to understand)
    - You would need to meet the trial's strict criteria and time frames (blood results etc may take some time to come back to determine eligibility)
    - You would need to physically consent to trial participation (may not be able to talk if ventilated)
    - If you're unable to consent, next of kin may be able to agree (must get to the hospital to sign for patient; not allowed in the COVID wards to efficiently communicate with the patient's wishes etc).

    All of the above while your body's fighting for life.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.